XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.3
Share-based Compensation - Equity Award Modification (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 24, 2024
Jan. 10, 2024
Mar. 16, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Share-based Compensation              
Share based payment award, option to vest (in years)     4 years        
Share-based compensation expense       $ 8,646 $ 2,577 $ 13,981 $ 7,261
Chief Executive Officer ("CEO")              
Share-based Compensation              
Share based payment award, options, vested, number of shares 1,700,000     1,700,000   1,700,000  
Share based payment award, option to vest (in years) 3 years            
Share-based compensation expense       $ 5,900   $ 5,900  
Options vested and exercisable 250,000     250,000   250,000  
Chief Medical Officer (the "CMO")              
Share-based Compensation              
Share based payment award, options, vested, number of shares   67,525          
Share based payment award, equity instruments other than options, vested in period   40,515          
Share based payment arrangement, expense reversal           $ 100